Evaluation of peripheral intravenous volume analysis in patients receiving haemodynamic monitoring

Not Applicable

• Conditions: cardiovascular instability; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12619000899145
• Lead Sponsor: Austin Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-06-26
• Last Update Posted: 21 September 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

adult aged equal to or older than 18 years
expected to under go surgery with invasive haemodynamic monitoring
expected to admitted to the intensive care unit and receiving haemodynamic montoring

Exclusion Criteria

No invasive hemodynamic monitoring planned
No invasive hemodynamic monitoring present
No peripheral venous catheter present
Female patients who are pregnant or lactating
Active irregular heart rhythm
Congenital heart disease
Restrictive cardiomyopathy (e.g. due to amyloidosis)
Severe mitral stenosis, moderate or severe aortic stenosis, or mitral or aortic valve replacement
Extracorporeal circulation (e.g. cardiopulmonary bypass, LVAD, ECMO, or active dialysis during measurement)
Dual lung ventilation
Use of vasopressors, starches, lipids (including propofol), or dextrose solutions greater than 5% concentration through the IV line.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in blood pressure derived from the PIVA sensor[Changes in the venous waveform assessment of volume status from baseline over a minimum period of 2 hours]

Secondary Outcome Measures

Name	Time	Method
Ease of PIVA use[Questionnaire to be completed by bedside staff after a minimum of 2 hours use with a determination of 'strongly disagree/disagree/neutral/agree/strongly agree being recorded];Difficulty to use PIVA[Questionnaire to be completed by bedside staff after a minimum of 2 hours use with a determination of 'strongly disagree/disagree/neutral/agree/strongly agree being recorded];Assessment of difficultly to obtain good quality data while monitoring with the PIVA device[Questionnaire to be completed by bedside staff after a minimum of 2 hours use with a determination of 'strongly disagree/disagree/neutral/agree/strongly agree being recorded];Change in fluid balance occurring over the first 2 hours of PIVA monitoring period[Changes in the fluid balance state from baseline over a minimum period of 2 hours]